A medical emergency in a gym class started Megann’s life-changing journey with epilepsy, including a sudden diagnosis and intense treatment plan. Discover Megann’s inspiring story, detailing her challenges with treatment, loss of independence and how she empowers herself and other to live life to the fullest.

Jesse was a senior in college studying to become a doctor when he was diagnosed with acute lymphoblastic leukemia (ALL). His studies in the medical field inspired him to ask critical questions and advocate for himself throughout his ALL journey. By combining this determination with a positive attitude, Jesse navigated one of the most challenging times of his life with resilience and hope.

Rachael was just 36 years old when she was diagnosed with breast cancer. Her decade long treatment journey has left its mark and worries for the future, but emerging out of the darkness is a cherished son she wasn’t sure if she could have, a powerful drive to help others on their cancer journeys and true perspective on what matters in life.

Scientific advances are reshaping how small cell lung cancer is understood and treated. As interest grows in first-line maintenance strategies, researchers are exploring new ways to extend the impact of initial therapy in this historically difficult-to-treat cancer.

We strive to put patient priorities first in our research, advancing our understanding of sleep conditions and the needs of those with narcolepsy and idiopathic hypersomnia.

Narcolepsy is a chronic, neurologic sleep disorder, and people living with the condition are at increased risk of developing cardiovascular (CV) and cardiometabolic (CM) comorbidities. New expert consensus recommendations provide more clarity on these risks, including obesity, diabetes, dyslipidemia as well as hypertension and offer actionable behavioral, therapeutic, and dietary strategies that aim to holistically mitigate these risks.

We are focused on advancing innovation where it matters most for people facing some of the toughest cancers. Explore how our commitment to high-unmet need diseases like extensive-stage small cell lung cancer (ES-SCLC) is helping to drive meaningful progress in cancer care.

March 26^th marks Purple Day – a pivotal moment in time to recognize and support millions of people around the world who are living with epilepsy. We’re using this day to pause and reflect on the progress that has been made for people in the epilepsy community and advance our purpose to innovate to transform the lives of patients and their families.

Watch Sarah McMahon, Senior Vice President, Sleep Franchise Head, highlight the importance of recognizing the realities of people living with sleep conditions to inform innovation and care.